medline.ch Onkologie Magen-Darm

	Risk of colorectal cancer incidence and mortality after removals of polyps: a cohort study using the UK Biobank. Ann Gastroenterol Wan Z, Du H, Kang X, Jiang S, Mi J, Liu Z, Zhou R, Jiang L, Zhao N, Li G, Han W, Wong SH, Bai X, Yang H. PMID: 42460415 [PubMed]
	Epidemiology of Early-Onset Colorectal Cancer: A Systematic Review and Meta-Analysis of Incidence, Temporal Trends, and Associated Factors. Cureus Ahmad M, Talpur AS, Solangi Z, Qadri H, Talat F, Chauhan N, Becirovic F, Roosevelt A, Azeem M, Tabassum A, Mahboob MJ, Usman H, Naseer-Ud-Din SM, Siddiqui A, Muhammad L, Ben Selma A, Javaid T. PMID: 42460186 [PubMed]
	Endoscopic mucosal resection versus endoscopic submucosal dissection for early colorectal cancer and precursor lesions: a retrospective study. Front Med (Lausanne) Yang M, Fan C, Li Z, Pan L, Cheng J. PMID: 42460082 [PubMed]
	Toward oral nanomaterial-based drug delivery systems for hepatocellular carcinoma therapy: evidence mapping, route-specific validation, and translational challenges. Front Pharmacol Fu Y, Ge Y, Yi S, Peng Q, Jiang H, Zhou J. PMID: 42460010 [PubMed]
	C-reactive protein flare-response predicts the efficacy of PD-1 inhibitors in metastatic gastric cancer. Front Immunol Lei YH, Zheng H, Song XF, Wang YY, Cai FB. PMID: 42459697 [PubMed - in process]
	Optimizing immunotherapy in advanced gastric cancer: established and emerging biomarkers for precision patient selection. Front Immunol Rao X, Huang G, Li J, Wu C, Yang M, Rao X, Qian Z, Chen L, Yang Y, Wei W. PMID: 42459676 [PubMed - in process]
	Recent applications of artificial intelligence in cancer radiotherapy and immunotherapy: current status and future directions. Front Immunol Shi Q, Xuan M, Lv C, Zhang Z, Geng X, Huang D, Hu X. PMID: 42459675 [PubMed - in process]
	Immune checkpoint inhibitors in dMMR-MSI-H colorectal cancer: rationale, progress and prospects. Front Immunol Xu G, Liang D, Li L, Cheng J, Wang X. PMID: 42459668 [PubMed - in process]
	Efficacy and safety of first-line chemoimmunotherapy versus chemotherapy alone for advanced pulmonary lymphoepithelioma-like carcinoma: a systematic review and real-world cohort study. Front Immunol Chen F, Su Y, Zeng X, Jiang M, Huang Y, Pan L, Xiao L, Qin YR, Cen X, Bai J. PMID: 42459654 [PubMed - in process]
	Decoding the PTM code of cGAS-STING in gastric cancer: from innate DNA sensing to precision combination therapy. Front Immunol Li Q, Peng Y, Liu D, Ma X, Wu Y. PMID: 42459646 [PubMed - in process]
	An ecological time series study of lagged associations between pesticide use and cancer incidence in Ukraine. Front Public Health Kondratiuk M, Antonenko A, Omelchuk S, Melnychuk F, Kovalchuk O, Kobyliak N, Borysenko A. PMID: 42459454 [PubMed - in process]
	Molecular and metabolic dysregulation of lung cancer in developing anti-tumor activity by gambogic acid mediated mTOR signaling: in vitro and computational study. 3 Biotech Bo S, Liao Y, Chen X, Liu L, Pang F, Zhou L. PMID: 42459409 [PubMed]
	Deep learning in multi-omics integration for gastrointestinal cancer biomarker discovery. Front Oncol Lv J, Liu D, Guo L, Wang Y, Wang J, Huang J. PMID: 42459316 [PubMed]
	Survival outcomes of low-dose and high-dose bevacizumab front-line maintenance in advanced high-grade serous ovarian cancer: a propensity score-matched real-world study. Front Oncol Wu T, Shen Y, Wang X, Xi R, Hu L, Lu J, Wang G, Zhang P. PMID: 42459309 [PubMed]
	The gut microbiota in colorectal cancer: role in cytokine regulation, intestinal immune barrier dysfunction. Front Oncol Zhou P, He Y, Qu H, Zhou Y, Pan H. PMID: 42459302 [PubMed]
	Peripheral blood immune cell subsets predict postoperative recurrence in colorectal cancer: a flow cytometry-based retrospective study. Front Oncol Xu Y, Cheng Q, Yang H. PMID: 42459299 [PubMed]
	Tumor microenvironment-oriented HNGCIscore identifies immunotherapy-sensitive subgroups in ICI retreatment of HER2-negative advanced gastric cancer. Front Oncol Song X, Wu Y, Zhu Y, He Y, Shi J, Ren K, Gao C. PMID: 42459296 [PubMed]
	Integrating Methylation Signature Modifications and Subtype Classification into a Prognostic Risk Model for Survival Prognosis and Predicting Immunotherapy Response in Colorectal Cancer. Curr Med Chem Chen R, Yao Z, Jiang L, Hu J. PMID: 42458941 [PubMed - as supplied by publisher]
	Indocyanine green-guided robotic-assisted mesorectal lymphadenectomy for high-risk T1 rectal carcinoma: Preliminary results of a prospective cohort study (IDEAL stage 2a). Colorectal Dis Rouanet P, Flori N, Bouazza N, Houmada A, Khellaf L, Taoum C. PMID: 42458874 [PubMed - in process]
	Dosimetric superiority of proton radiosurgery in liver cancer: an in silico comparative dosimetric study. BMC Cancer Li J, Ma T, Zhou H, Feng C, Liu L, Liu L, Li L, Shan C, Zheng D, Yuan S. PMID: 42458374 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 242557

Seite 1 von 12128

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung